miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD.
Hu T, Chang YF, Xiao Z, Mao R, Tong J, Chen B, Liu GC, Hong Y, Chen HL, Kong SY, Huang YM, Xiyang YB, Jin H.
Hu T, et al. Among authors: chen hl, chen b.
Oncotarget. 2016 Dec 27;7(52):86103-86116. doi: 10.18632/oncotarget.13344.
Oncotarget. 2016.
PMID: 27861141
Free PMC article.